Skinstylus®设备近日获得美国食品药品监督管理局（FDA）的新许可，其适用范围扩展至改善所有皮肤类型的眶周皱纹。这一监管进展意味着该技术将能为更广泛的患者群体提供非侵入性的皮肤年轻化治疗方案。
Skinstylus®设备近日获得美国食品药品监督管理局（FDA）的新许可，其适用范围扩展至改善所有皮肤类型的眶周皱纹。这一监管进展意味着该技术将能为更广泛的患者群体提供非侵入性的皮肤年轻化治疗方案。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.